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Abstract 
This  study  investigated  the  effects  of  royal
jelly (RJ) on acetic acid-induced colitis in rats.
Twenty  adult  female  Wistar  albino  rats  were
divided into four treatment groups of 5 animals
each, including a control group (Group I); Group
II was treated orally with RJ (150 mg kg
–1 body
weight); Group III had acetic acid-induced coli-
tis; and Group IV had acetic acid-induced colitis
treated orally with RJ (150 mg kg
–1 body weight)
for 4 weeks. Colitis was induced by intracolonic
instillation of 4% acetic acid; the control group
received physiological saline (10 mL kg
–1). Colon
samples were obtained under deep anaesthesia
from animals in all groups. Tissues were fixed in
10% formalin neutral buffer solution for 24 h and
embedded in paraffin. Six-micrometre-thick sec-
tions were stained with Mallory’s triple stain and
toluidine blue in 1% aqueous solution at pH 1.0
for 5 min (for Mast Cells). RJ was shown to pro-
tect the colonic mucosa against the injurious
effect of acetic acid. Colitis (colonic damage)
was confirmed histomorphometrically as signifi-
cant increases in the number of mast cells (MC)
and colonic erosions in rats with acetic acid-
induced colitis. The RJ treatment significantly
decreased the number of MC and reduced the
area of colonic erosion in the colon of RJ-treated
rats compared with rats with untreated colitis.
The results suggest that oral treatment with RJ
could be used to treat colitis. 
Introduction 
The  constant  exposure  of  the  intestinal
epithelium to diverse types of nutrients and
microorganisms present in the natural flora
leads  to  permanent  stress  for  enterocytes.
Mucosal surfaces of the intestinal tract repre-
sent  one  of  the  main  routes  for  microbial
pathogens to enter a host and are important
sites of microbially induced diseases.
1
Natural compounds, such as components of
green tea and RJ, can play a significant role
against inflammation, cancer,
2 cell prolifera-
tion
3 and  liver  damage.
4 RJ  is  a  traditional
product  commonly  used  to  supplement  the
medical  treatment  of  various  diseases.  It  is
secreted  from  the  hypopharyngeal  and
mandibular glands of young worker bees, to
feed young larvae and the adult queen bee.
4 RJ
contains many important compounds with bio-
logical activity, such as free amino acids, pro-
teins, sugars, fatty acids, minerals (e.g. iron
and calcium) and vitamins (mainly thiamine,
niacin, riboflavin).
5,6 Several reports in the lit-
erature  demonstrate  the  immunomodulatory
properties of RJ.
7-9
The ability of MCs to release proinflamma-
tory and immunoregulatory mediators has led
to speculation that they are involved in gas-
trointestinal  pathologies,  such  as  intestinal
allergy,  coeliac  disease  and  inflammatory
bowel disease (IBD). In patients with IBD, the
numbers of intestinal MC are increased. They
have been shown to account for 60 and 30% of
all mucosal cells immunoreactive for tumour
necrosis factor (TNF)-a and interleukin (IL)-
5,  respectively.
10-13 In  previous studies,  many
authors identified changes in MCs in inflam-
matory  bowel  diseases,  including  ulcerative
colitis.
14,15 In  addition,  in  vitro studies  with
MCs  isolated  from  intestinal  tissue  demon-
strated  increased  release  of  histamine  and
eicosanoids in MCs derived from patients with
IBD  compared  with  control  patients.
16 Such
data  support  the  hypothesis  that  MCs  are
primed or preactivated by the local inflamma-
tory tissue environment.
17
Intracolonic application of acetic acid has
long  been  used  as  an  artificial  method  to
induce  colitis  in  experimental  animals.
18,19
Although it is known that the MC population
in the intestine may be involved in pathologi-
cal changes in the colon, very few data are
available on changes in the number and distri-
bution of MCs in colon of subjects with colitis.
These parameters were therefore investigated
in  this  study,  which  also  examined,  for  the
first time, the effect of RJ on numerical distri-
bution of MCs and on the ability of rat colonic
mucosa tissue to generate after acetic acid-
induced colitis. The aim of the present study
was to evaluate the protective and antioxida-
tive effect of RJ in acetic acid-induced colonic
damage by determining changes in tissue his-
tology and number of MCs.
Materials and Methods
Animals
Twenty  adult  female  Wistar  albino  rats
(n=5ﾥ4) weighing about 300 g were obtained
from  the  Laboratory  of  Animal  Science,
Medical  School,  Fırat  University,  Elazıg,
Turkey. The animals were given standard rat
pellets (Van Feed Factory, Van, Turkey) and tap
water ad libitum and were housed in individ-
ual cages (360ﾥ200ﾥ190 mm
3), each contain-
ing 2 or 3 animals, from 7 days before the start
of the experiment. 
The rats were divided into four equal groups
[Group I – control group, Group II – royal jelly-
treated  (RJ),  Group  III  –  acetic  acid-treated
(Colitis)  and  Group  IV  –  acetic  acid-treated
(Colitis) + royal jelly (CRJ)]. Group I received
normal food and water during the experiment.
Group II received normal food and royal jelly
(150  mg/kg
–1)  suspended  in  water.  Group  III
received normal food and a dose of acetic acid
dissolved in 0.9% NaCl delivered via the anus to
the colon. Group IV received normal food along
with 150 mg/kg
–1 royal jelly and a per anus dose
of acetic acid dissolved in 0.9% NaCl. 
The RJ used was purchased from a local nat-
ural food store, Istanbul, Turkey. All animals
were  housed  in  stainless  steel  cages  under
standard  laboratory  conditions  (light  period
07.00 h to 20.00 h, 21±2°C, relative humidity
55%), and received humane care according to
the criteria outlined in the Guide for the Care
and Use of Laboratory Animals prepared by the
National Academy of Sciences and published
by the National Institute of Health. 
Amino acid content of royal jelly
The amino acid content of the RJ used is
given in Table 1. The main amino acids present
were  lysine  (62.4  mg  100  g
–1)  and  proline
(58.76 mg 100 g
–1).
Induction of experimental colitis
All experimental animals were fasted for 24
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h  before  induction  of  colitis.  Each  rat  was
lightly anesthetised with ether, and a polyeth-
ylene cannula was inserted into the lumen of
the colon via the anus. The tip of the cannula
was positioned at 8 cm proximal to the anus.
Either 1 mL of acetic acid (4% vol/vol in 0.9%
NaCl) or saline as the inert control was slowly
infused into the distal colon. After 30 seconds
exposure, 1 mL of saline (0.9%) was instilled
in  order  to  withdraw  the  previous  solution
from the colon.
18
Histological analysis
One month after experiment beginning, rats
were sacrificed under ether anaesthesia and
the colon of each animal was excised and gen-
tly rinsed under tap water. The colon was then
stretched on a piece of cork with mucosal sur-
face  upwards  in  the  standard  position  for
macroscopic examination and the severity of
colitis was scored with the help of a magnify-
ing glass. Finally, the colon was dissected and
fixed in 10% formalin neutral buffer solution at
room temperature for 24 h and cross-sections
were processed routinely for light microscopy.
Sections of 6mm were stained with Mallory’s
triple stain and examined under a light micro-
scope. 
Mast cell analysis
Colon tissues fixed in 10% formalin neutral
buffer  solution  for  24  h  were  embedded  in
paraffin. Sections of 6 mm thickness were cut
and  stained  with  0.5%  toluidine  blue  (Gurr,
England) in 0.5 N hydrochloric acid at pH 0.5
for 30 min.
20 Tissue sections were examined
under light microscopy (x400) and the number
of MCs per square millimeter were counted in
random  high-power  fields  using  a  Nikon
Optiphot 2 (Japan) light microscope incorpo-
rating a square graticule in the eyepiece (eye-
piece x10, objective x40, a total side length of
0.225 mm). Intact and partially degranulated
MCs were counted in 100 high-power fields in
colon preparations of each group. The MC den-
sity at each site was calculated and recorded as
MC numbers mm
–2. 
Statistical analyses
The results are expressed as mean ± stan-
dard deviation. The Bartlett test was used in
order  to  determine  the  heterogeneity  of  the
data. The Bonferroni multiple comparison pro-
cedure was then utilised for identifying differ-
ences among means. Differences were consid-
ered significant at P<0.05.
Results
Light microscopy examination of the colon
mucosa of control rats (Group I) and RJ rats
(Group II) stained with Mallory’s triple stain
showed normal mucosal (crypts) glands with
intact epithelial surfaces (Figure 1A, B). The
surface epithelium and the crypt architecture
were normal, comprising columnar epithelial
and  goblet  cells.  The  rats  with  acetic  acid-
induced  colitis  (Group  III)  exhibited  severe
damage to the colon mucosa, with pathologi-
cal changes including massive destruction of
the epithelial layer and cellular debris, haem-
orrhagic colitis in the colon mucosa and gross
lesions  in  the  colon.  The  main  histological
finding was the presence of necrosis associat-
ed  with  haemorrhage.  Histology  revealed
coagulative necrosis of the surface epithelium
and  some  crypts  with  focal  ulceration.
Microscopic examination of the colon mucosa
showed lesions that varied in extent and depth
(Figure 1 C).
Oral treatment with 150 mL kg
–1 RJ gave a
protective  effect  against  acetic  acid-induced
colitis in Group IV rats. The colon mucosa of
these rats showed superficial ulceration and
slight focal congestion and the crypts appeared
normal. Mild cellular infiltration was apparent
in the lamina propria and submucosa (Figure
1 D), while the protective effect was mild with
150 mg kg
–1 dose of RJ. 
The numbers of MCs in the colon increased
after acetic acid administration, but the num-
ber of colonic MCs in the colitis + RJ group
(Group IV) was significantly lower than that in
the colitis group. The histological appearance
and distributions of numbers of MCs is sum-
marized in Figures 2 and 3. 
Discussion
This study demonstrates for the first time
Table 1. Free amino acid content of the RJ
used in the experiment (mg/100 g).
4
Aspartic acid  17.33
Serine  1.39
Glycine  1.66
Lysine  62.43
Cysteine  1.29
Glutamic acid  2.99
Threonine  1.15
Alanine  1.14
Proline  58.76
Valine  3.29
Methionine   -
Tyrosine  1.29
Tryptophan  -
Histidine  -
Arginine   -
Cystine  21.76
Phenylalanine  1.49
Hydroxyproline  1.61
Leucine-isoleucine  1.51
Glutamine  1.46 
Figure 1.  Histological analysis of the colon section. (A) Control group; (B) Royal Jelly
group, the section shows normal mucosal glands with intact epithelial surfaces. (C) Colitis
group, the section shows a severe damage to the colon mucosa, with including massive
destruction of the epithelial layer. (D) Colitis + Royal Jelly group, the section shows a
superficial ulceration. Magnification A, B, C = 180X and D = 100X. H&E.[European Journal of Histochemistry 2010; 54:e35] [page 195]
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that RJ has beneficial effects on the colon of
rats  with  acetic  acid-induced  colitis.
Introduction  of  acetic  acid  into  the  colon
lumen induced gross lesions in the mucosal
part of the intestine and caused typical colitis
damage,  which  was  confirmed  histomorpho-
metrically  by  significant  increases  in  diar-
rhoea, congestion and swelling.
18 Pronounced
destructive changes associated with ulcerative
colitis and haemorrhages were also observed
in the colon of rats with acetic acid-induced
colitis. 
Treatment of colitic rats with an oral dose of
RJ gave a degree of recovery from acute colitis.
The  anti-colitogenic  effects  of  RJ  could  be
attributed to improvement of the antioxidant
status of the animals due to an increase in
mucin  content  of  the  colon  mucosa.
21
Polyphenolic compounds in their many forms
are the main components responsible for the
functional  properties  associated  with  many
foods, such as antioxidant capacity
22,23and anti-
inflammatory capacity.
24 RJ contains polyphe-
nolic  compounds  collected  by  bees  from  the
plants where they gather nectar.
25
Previous studies
25,26 suggested that Nigella
sativa oil  could  protect  the  gastric  mucosa
against ethanol-induced ulcer. Kanbur et al.
4
reported that RJ protects against liver damage
induced by paracetamol. 
RJ has been shown to exhibit anti-inflamma-
tory,  DNA-protective,
27 and  anti-tumour,
28,29
effects in experimental animals. Hamerlinck
30
reported that RJ exhibited immunomodulatory
properties by stimulating antibody production
and  immunocompetent  cell  proliferation  in
mice or by depressing humoral immune func-
tions in rats. Another report indicated that the
protection imparted by RJ ingestion could be
partly attributed to the presence of neopterin in
RJ.
30 The protection afforded by RJ against the
immunosuppression  produced  by  increased
PGE2 levels has been demonstrated in studies
in vivo
31 and in vitro.
27
El-Nekeety et al.
9 found a potential protec-
tive effect of RJ against the toxic hazards of
fumonisins. Kamakura et al.
32 reported that RJ
in the diet decreased the gene expression of
cytochrome  P450  4A14  (CYP4A14)  enzymes
and detoxifying enzymes, which catalyse per-
oxidation of endogenous lipids, and increased
the  gene  expression  of  glutathione  S-trans-
ferase and glutathione peroxidase. 
Ethanol  has  been  proven  to  cause  gastric
damage, an effect confirmed histomorphomet-
rically by significant increases in the number
of MC and gastric erosions.
33 In the present
study, acetic acid-induced colitis caused pro-
nounced destructive changes associated with
haemorrhage in the colon of affected rats, as
well as increasing number of MC (Figure 2 C).
The ulcerative erosions in colon tissues of rats
with  acetic  acid-induced  colitis  decreased
when the animals were treated with RJ (Figure
2 D). In addition, RJ prevented any increase in
the number of MCs. Oral treatment with an
aqueous solution of RJ (150 mL kg
–1) demon-
strated a good level of colitis protection. 
These findings are in good agreement with
recent results presented by El-Dakhakhny et
al.,
26 and Kanter et al.,
34 who found that Nigella
sativa had  a  gastroprotective  action  in  an
ethanol-induced ulceration model. 
Gebbers et al.
35 observed an increase in the
number of IgE positive plasma cells and the
appearance of intraepithelial MCs in patients
with rectal spirochaetosis. Morris et al.
36 sug-
gested  that  MCs  numbers  increased  in
inflamed tissues 3-4 weeks after colitis induc-
tion. In other studies, an increased MC count
in the 5-20 day period
37 and an elevated MC
protease-2  (RMPC-2)  level  at  3  weeks  were
reported  in  colonic  tissue  taken  from  TNBS
rats.
38 Xu et al.
37 reported that MC numbers in
the  colon  of  Sabra  rats  with  TNBS-induced
colitis  were  lower  during  the  first  five  days
after induction. 
As  a  result,  while  acetic  acid  application
caused damage to the colon mucosa of rats,
treatment with RJ was found to diminish the
harmful effects of acetic acid. Although it has
been considered that it might exert the bene-
fits through its antioxidant features, the exact
mechanism of effect is yet unknown. In con-
clusion, it could be suggested that the efforts
to focus on the effect mechanism/s of RJ and
other traditional medicinal supplements may
provide new opportunities for the development
of useful drugs. 
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